Personalized medicine: Lung Cancer leads the way-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized medicine: Lung Cancer leads the way

Published:2013 Issue:2 Volume:50 Page:77
ISSN:0019-509X
Container-title:Indian Journal of Cancer
language:en
Short-container-title:Indian J Cancer

Author:

Parikh P,Puri T

Publisher

Medknow

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools;Journal of Biomolecular Structure and Dynamics;2022-12-16

2. A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution;Lung India;2022

3. Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India;South Asian Journal of Cancer;2021-12

4. Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region;International Journal of Molecular & Immuno Oncology;2021-05-29

5. Why we should rely only on molecular tests based on Indian data;International Journal of Molecular & Immuno Oncology;2020-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP